Related Experiment Video
Updated: Jun 17, 2026
An Orthotopic Resectional Mouse Model of Pancreatic Cancer
Published on: September 24, 2020
ASO Visual Abstract: Benefit of Adjuvant Therapy after Neoadjuvant Therapy and Resection for Patients with Pancreatic
Michael C Frey1, Victor Lopez-Lopez2, Alessia Benz1
1Department of Surgery and Transplantation, University Hospital Zürich, Zurich, Switzerland.
Annals of Surgical Oncology
|June 15, 2026
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Clinicopathological Significance of Leucine-rich Repeat-containing 15 in Distal Extrahepatic Bile Duct Carcinoma.
Applied immunohistochemistry & molecular morphology : AIMM·2026
Benefit of adjuvant chemotherapy for resected pancreatic cancer following neoadjuvant FOLFIRINOX or Gemcitabine-Nab-paclitaxel: a multinational analysis.
Journal of the National Cancer Institute·2026
Does neoadjuvant therapy reduce pancreatic fistula after pancreatoduodenectomy and distal pancreatectomy?-a systematic review and meta-analysis.
Hepatobiliary surgery and nutrition·2026
Disparities in Active Surveillance of Papillary Thyroid Microcarcinomas.
Annals of surgical oncology·2026
Fertility Preservation Pathways in Young Women With Breast Cancer: A Single-Center Analysis in a Publicly Funded System.
Annals of surgical oncology·2026
KRAS and TP53 Circulating Tumor DNA are Prognostic in Localized Pancreatic Cancer.
Annals of surgical oncology·2026
A Phase 1 First-Time-in-Human, Open-Label Study of Nelistotug Administered to Patients with Advanced Solid Tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research·2026
Non-pharmacological interventions and quality of life in female survivors of hormone receptor-positive breast cancer receiving adjuvant endocrine therapy: A systematic review.
Anales del sistema sanitario de Navarra·2026
Advances and future perspectives in the treatment of small cell lung cancer: From chemotherapy and radiotherapy to the era of targeted therapy and immunotherapy.
Journal of cancer research and therapeutics·2026
Rethinking intensive salvage therapy in the venetoclax era.
Haematologica·2026